Finger Movement Training for Stroke
Trial Summary
What is the purpose of this trial?
Human development as a species has been strongly associated with the ability to dexterously manipulate objects and tools. Unfortunately, current therapy efforts typically fail to restore fine manual control after stroke. The goal of this study is to evaluate a new intervention that would combine targeted electrical stimulation of selected nerves with use a soft, pneumatically actuated hand exoskeleton to enhance repetitive practice of independent movements of the fingers and thumb in order to improve rehabilitation of hand function after stroke. The investigators will recruit stroke survivors in the subacute phase of recovery (2-18 months post-stroke). These participants will be involved in a 5-week intervention involving 15 training sessions. During these sessions, participants will train independent movement of the digits of the paretic hand. Evaluation of motor control of the paretic hand will occur prior to initiation of training, at the midpoint of the training period, after completion of training, and one month later.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Actuated Hand Exoskeleton, Soft, Pneumatically Actuated Hand Exoskeleton, Occupational Therapy, OT, Occupational Rehabilitation, Ergotherapy for stroke patients?
Research shows that robotic hand movement therapy, like HEXORR II, can improve hand function and reduce muscle tightness in stroke patients. Additionally, home-based therapy with devices like HandSOME II has been shown to improve hand movement and real-world use of the impaired limb, with benefits lasting for months.12345
Is finger movement training using hand exoskeletons safe for humans?
Research on various hand exoskeleton devices, including HandSOME II, HEXORR II, and RobHand, shows they are generally safe for use in humans, with no significant adverse events reported. Studies on healthy individuals and stroke patients found these devices comfortable and reliable, with no serious side effects.23678
How is the Actuated Hand Exoskeleton treatment different from other treatments for stroke rehabilitation?
The Actuated Hand Exoskeleton is unique because it uses soft, pneumatically controlled actuators to help stroke survivors extend their fingers, allowing for more natural hand movements. Unlike other devices, it is lightweight and conforms to the hand's shape, providing independent assistance to each finger while allowing full arm movement, which is crucial for effective rehabilitation.59101112
Eligibility Criteria
This trial is for stroke survivors who are 2-6 months post-stroke, can consent, see shapes on a screen, and have moderate to mild hand impairment without severe pain or joint issues that would prevent movement.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 5-week intervention involving 15 training sessions to improve hand function using targeted electrical stimulation and a hand exoskeleton
Follow-up
Participants are monitored for safety and effectiveness after treatment, with evaluations occurring at the midpoint, after completion, and one month later
Treatment Details
Interventions
- Actuated Hand Exoskeleton
- Occupational Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
North Carolina State University
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator